Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05522972

Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games

Improving Normal and Amblyopic Vision With Video Games and Perceptual Learning

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Nova Southeastern University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia.

Detailed description

Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. Our previous findings (see Publications) show that the adult amblyopic brain is still plastic and malleable, suggesting that active approach is potential useful in treating amblyopia.The goal of this project is to assess the limits and mechanisms of neural plasticity in both normal and amblyopic spatial vision. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia. Research participants will be asked to practice a visual discrimination task (perceptual learning) or to play video games with the amblyopic eye for a period of time. A range of visual functions will be monitored during the course of treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALVideo Game Vision TrainingA new approach for improving amblyopic vision using video games
BEHAVIORALPerceptual LearningA new approach for improving amblyopic vision with perceptual learning
BEHAVIORALOcclusion TherapyConventional treatment for amblyopia

Timeline

Start date
2022-09-13
Primary completion
2029-08-31
Completion
2029-08-31
First posted
2022-08-31
Last updated
2025-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05522972. Inclusion in this directory is not an endorsement.